跳到正文
原文
Becker's Hospital Review· Ella Jeffries·· 2026-10-06AI 评分49

BD 19亿美元协议扩展美国医疗物资生产

BD strikes $19B deal to expand US medical supply production

AI 导读

BD 与美国政府达成协议,计划在未来数年内投资 19 亿美元,其中 30 亿美元用于扩张美国制造产能,预计每年增产约 50 亿件基础医疗耗材,使美国本土供应占比提升至 80%。协议允许 BD 在达成相关里程碑的情况下,就特定产品和投入豁免未来的 232 条款关税。

正文

BD has entered a partnership with the U.S. government to expand domestic manufacturing and supply chain capacity for essential medical consumables.

The company intends to invest $19 billion in the U.S. over several years, including $3 billion toward U.S. manufacturing expansion, according to an Oct. 6 news release.

BD plans to expand U.S. production by approximately 5 billion essential medical consumables annually, raising its share of domestically supplied essential medical consumables to roughly 80%. It also intends to manufacture 100% of BD needles used in America domestically using American-made steel.

The agreement allows BD to be exempt from future Section 232 tariffs on covered BD products and inputs, subject to the final scope and implementation of future Section 232 actions and BD’s achievement of agreed milestones.

The announcement lands as hospital groups press for protection from tariffs on medical goods. The AHA asked USTR in July to exempt medications, medical devices and PPE from forced-labor tariffs, citing data showing 94% of plastic gloves and about half of medical devices used in the U.S. are imported. The federal government has also backed domestic production directly, with the Economic Development Administration investing $15.97 million in a Civica-led project to build a fully domestic supply chain for four sterile injectables. 

The post BD strikes $19B deal to expand US medical supply production appeared first on Becker's Hospital Review | Healthcare News & Analysis.

来源:Becker's Hospital Review · beckershospitalreview.com